Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency.
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000311:Adrenal Glands / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000378:metabolism*; D003480:Cushing Syndrome / Q000188:drug therapy*; D003907:Dexamethasone / Q000627:therapeutic use; D003632:Dichlorodiphenyldichloroethane / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004064:Digestive System / Q000187:drug effects; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D007668:Kidney / Q000502:physiology; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D008928:Mitochondria; D012964:Sodium / Q000378:metabolism
D015065:17-Hydroxycorticosteroids; D000450:Aldosterone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D012964:Sodium; D003632:Dichlorodiphenyldichloroethane; D006854:Hydrocortisone